BOSTON, March 03, 2022–(BUSINESS WIRE)–binx well being, a healthcare expertise and diagnostics firm that makes routine testing handy by enabling entry to care the place individuals stay, work, examine, and store, introduced at this time the appointment of Jeff Grosklags, an achieved trade chief and UnitedHealth Group’s Optum Rx Chief Monetary Officer (CFO) to its Board of Administrators. For the previous 16 years, Grosklags has labored in a monetary management capability inside Optum and UnitedHealth Group.
“We’re thrilled to welcome Jeff to the binx Board of Administrators given his a long time of enterprise and healthcare management, and his ardour for care entry,” stated Jeff Luber, CEO of binx well being. “In a quickly altering atmosphere for healthcare supply, we’re lucky to have the breadth of expertise we do within the binx board and know that Jeff can be an unlimited complement to our mission of ‘In all places Care.’”
With greater than 25 years of management expertise, Grosklags brings vital strategic, operational, and monetary experience to the corporate. At the moment, he’s the CFO of Optum Rx, a UnitedHealth Group firm, one of many largest pharmacy care service corporations in america, serving 60 million People nationwide, 67,000 community pharmacies, and over $100B in managed drug spend. Previous to turning into CFO of Optum Rx, Grosklags held quite a lot of senior management positions inside UnitedHealth Group, together with CFO of Optum Well being Care Options, Optum Well being Care Supply and COO and CFO of Optum Monetary Companies. Previous to becoming a member of UnitedHealth Group in 2006, he served in quite a lot of management positions at Metris Firms, together with CFO of the bank card enterprise and Senior Vice President of Finance. Grosklags beforehand served as a senior auditor for Deloitte and holds a level in Enterprise Administration with a focus in accounting from the College of St. Thomas.
“Sufferers are trying past clinic settings and are demanding care options that match their busy existence,” Grosklags stated. “binx is nicely positioned to play a major position on this period of healthcare with their dedication to utilizing innovation and expertise to extend healthcare entry and fairness. I’m excited to affix the binx well being board of administrators.”
binx well being is working to enhance sexual well being and wellness by offering handy entry to high-quality testing that prioritizes medical integrity and shopper comfort. The binx well being options are designed to interrupt down screening boundaries by point-of-care onsite options and discreet patient-tailored at-home pattern assortment choices to be able to attain sufferers “in every single place”. In response to the pandemic, along with sexual well being and wellness, binx well being added COVID-19 packages which have confirmed very important in serving to their companions monitor, file and handle compliance with testing protocols.
About binx well being
binx well being is a healthcare expertise and diagnostics firm that makes routine testing handy by enabling entry to care the place individuals stay, work, examine, and store. The Firm works with massive company companions and establishments who’ve entry to massive affected person populations and have a major curiosity in delivering or facilitating higher healthcare to supply entry to and allow extra streamlined supply of diagnostic testing and care. Its omnichannel platform consists of the point-of-care io platform, which places central-lab high quality testing options within the palms of clinicians in every single place, and the Firm’s suite of physician-mediated and medical guideline-driven, at-home pattern assortment choices, which deliver high-quality testing, inhabitants well being instruments, and seamless digital integration functionality to these unable or unwilling to go to a clinic location.
binx’s io platform is the primary ever FDA-cleared, CLIA-waived point-of-care device for the detection of chlamydia and gonorrhea from female and male specimens that gives central lab efficiency leads to about thirty minutes. Its platform is extremely versatile, easy-to-use, and speedy, providing molecular point-of-care solutions at central-lab high quality efficiency and for the primary time enabling single-visit check and remedy. For extra info, go to www.binx.com.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20220303005410/en/